<p>A. Non-fasted (random) blood glucose throughout the treatment and monitoring phases. B. IPGTT comparing glucose tolerance in 120-day insulin-treated STZ-diabetic mice and non-diabetic controls. Txp – transplant.</p
<p>A) Body weight B) serum insulin levels, and C) blood glucose during i.p. glucose tolerance test (...
<p>Blood glucose levels measured at the indicated times after transplanting pancreatic IPCs into dia...
<p>Male control and DJ-1 KO mice at 12–13 weeks of age were treated with 40 mg STZ/kg body weight on...
<p>Diabetic mice received or not MSCs (A). Diabetic mice received or not insulin prophylaxis and/or ...
<p>At day 130 after diabetes induction, glucose tolerance was assessed in <i>normal</i>, <i>diabetic...
<p>A. Blood glucose levels of control and diabetic mice are shown as a function of time after the in...
<p>NIT-1 or NIT–hAAT cells were transplanted into diabetic mice. After transplantation, the blood su...
<p>The graph shows blood glucose levels in control or STZ-treated OX<sup>−/−</sup> and C57BL/6 mice ...
<p>A, IPGTT in control mice or treated with nicotinamide and streptozotocin (STZ) to generate glucos...
<p>Blood glucose levels were measured before streptozotocin (“preSTZ”) treatment, 3 weeks after the ...
<p>At day 130 after diabetes induction, pancreatic islets were observed (A) and quantified (B) in se...
<p>Panels A and B are average measurements of, respectively, non-fasting blood glucose and BLI signa...
<p>Mice were fasted overnight and then injected intraperitoneally with glucose (2 g/kg of body weigh...
<p>Mice received the indicated sample treatments for 5 weeks. Diabetes was induced by multiple (for ...
<p>(A,B) Fasting blood glucose (A) and insulin levels (B) in male non-progressing mice 30 weeks of a...
<p>A) Body weight B) serum insulin levels, and C) blood glucose during i.p. glucose tolerance test (...
<p>Blood glucose levels measured at the indicated times after transplanting pancreatic IPCs into dia...
<p>Male control and DJ-1 KO mice at 12–13 weeks of age were treated with 40 mg STZ/kg body weight on...
<p>Diabetic mice received or not MSCs (A). Diabetic mice received or not insulin prophylaxis and/or ...
<p>At day 130 after diabetes induction, glucose tolerance was assessed in <i>normal</i>, <i>diabetic...
<p>A. Blood glucose levels of control and diabetic mice are shown as a function of time after the in...
<p>NIT-1 or NIT–hAAT cells were transplanted into diabetic mice. After transplantation, the blood su...
<p>The graph shows blood glucose levels in control or STZ-treated OX<sup>−/−</sup> and C57BL/6 mice ...
<p>A, IPGTT in control mice or treated with nicotinamide and streptozotocin (STZ) to generate glucos...
<p>Blood glucose levels were measured before streptozotocin (“preSTZ”) treatment, 3 weeks after the ...
<p>At day 130 after diabetes induction, pancreatic islets were observed (A) and quantified (B) in se...
<p>Panels A and B are average measurements of, respectively, non-fasting blood glucose and BLI signa...
<p>Mice were fasted overnight and then injected intraperitoneally with glucose (2 g/kg of body weigh...
<p>Mice received the indicated sample treatments for 5 weeks. Diabetes was induced by multiple (for ...
<p>(A,B) Fasting blood glucose (A) and insulin levels (B) in male non-progressing mice 30 weeks of a...
<p>A) Body weight B) serum insulin levels, and C) blood glucose during i.p. glucose tolerance test (...
<p>Blood glucose levels measured at the indicated times after transplanting pancreatic IPCs into dia...
<p>Male control and DJ-1 KO mice at 12–13 weeks of age were treated with 40 mg STZ/kg body weight on...
DOI
Add to ORKG